Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief

Executive Summary

FDA invites public input in preparation for the seventh meeting of national authorities under the International Cooperation on Cosmetics Regulation, while The National Toxicology Program requests information on technologies and non-animal approaches that can be used to screen compounds for potential neurotoxicity. More news in brief.

Advertisement

Related Content

Editorial: 'Stink!' Documentary On Fragrance Ills Presents Nothing New, Effectively
Animal Welfare Group Making “Headway” With Regulators Across Globe
Valeant Builds Outside Of Dermatology With Bausch + Lomb Buy
Fragrance Groups Breathlessly Await EC Proposal On Allergens
In Brief
In Brief
NTP Five-Year Plan Prioritizes Collaboration, Anticipates Tech Innovations

Related Companies

Advertisement
UsernamePublicRestriction

Register

RS018476

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel